OTL-105

N/A

Report date: 2024/03/20 11:23:52

Base Information

Drug NameOTL-105
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapyCell and gene therapy > Cell therapy > Stem cell therapy > Hematopoietic stem cells therapy
Mechanisms of ActionPlasma protease C1 inhibitor gene transference
TargetsPlasma protease C1 inhibitor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOrchard Therapeutics Plc
China Registration ClassN/A

Develop Information

Active CompaniesOrchard Therapeutics Plc
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A